LINC01500

Across TCGA pan-cancer cohorts, LINC01500 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC01500 data layer compared with 18 for mass-spec protein.

The strongest signal is observed in acute myeloid leukemia (LAML), where higher LINC01500 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01500 expression acts as an unfavorable survival marker.

LAML are the cancer types where LINC01500 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Median	All	0.081	0.572	.003	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

LINC01500–LAML (DFS)

Open the LAML breakdown →